Page 8 of 26 • 1256 total posts
Goldman upgrade to $145 follows Q3 profit reversal and Macau's strongest monthly revenue since 2019, contradicting prior bearish thesis.
Wabtec finalizes €675 million Frauscher acquisition as promised, validating M\&A execution credibility and beginning three-year synergy realization timeline.
U.S. stocks closed lower Monday with volatility mixed and dispersion elevated. Overnight macro and AI headlines set the tone for a choppy Tuesday open.
MetLife closes $10B variable annuity risk transfer with Talcott, freeing capital for institutional retirement income expansion following Alight partnership.
Sponsor's $175M secondary offering at 18% discount triggered 35% price collapse. Institutional buyers caught underwater as valuation premium evaporates.
Unsolicited $1.6B all-stock bid forces board to weigh 30% premium against standalone recovery prospects amid bedding volume crisis and debt pressures.
Mali's $430M settlement and North American IPO study validate Elliott's separation thesis within two weeks, compressing expected timelines.
First Actuarial deal extends M\&A surge to UK pensions market, testing management's multi-regional execution capacity.
Federal judge allows breach-of-contract claims over delayed Breyanzi approval while December ASH presentations showcase next-generation hematology assets.
U.S. stocks faded into Monday’s close as volatility climbed and energy, utilities, and healthcare diverged sharply. Traders refocused on BOJ risks and ISM data.
Stocks extended an afternoon bid into the close, led by energy and defensives, while tech rallied on breadth even as Nvidia lagged. Volatility fell sharply.
Stocks grind higher into midday as Energy leads, volatility falls, and the CME outage fades from view. Tech diverges with INTC surging and NVDA lagging.
Comcast formally bid for Warner Bros. Discovery despite analyst warnings that Trump DOJ will block the deal. Board decision expected by year-end.
Q3 earnings and Investor Day disclose pro-forma RemainCo metrics, confirming March 2026 separation timeline amid Wind River impairment and trade headwinds.
Nov 6 call confirms HB 4384 delivered $0.12 benefit, unveils $26B capex through 2030, formalizes 6-8% EPS and dividend growth policy.
Black Friday open faces CME outage fallout. U.S. indices closed higher Thursday as cyclicals led; watch AI geopolitics, Europe data, and retail headlines today.
Stocks rose into the close Friday as energy, materials, and utilities outperformed while mega-cap tech steadied leadership. Volatility stayed contained.
Four major analyst upgrades and all-time high stock price confirm market repricing of Welltower's $23B seniors housing transformation program.
European Commission grants fourth Breyanzi indication with 82.7% response rate, reinforcing oncology execution despite pipeline challenges.
Stocks extended gains into Thanksgiving week as rate-cut hopes, AI infrastructure demand and crypto strength shaped risk appetite. Here’s what to watch.
U.S. stocks rose for a fourth session into the close, led by energy and staples, while the VIX fell to 17.19. Tech hardware rallied into the bell as software lagged.
Lo Li from Capital One joins Truist to lead consumer banking technology, signaling parallel execution on both wholesale and consumer expansion pillars of 2027.
Post-earnings momentum and 10th consecutive quarterly raise validate dividend sustainability despite Q3 consensus miss; valuation enters compelling territory.
Q3 2025 earnings show margin resilience amid bedding demand weakness, leaving recovery dependent on demand inflection rather than cost discipline.
Clorox beat Q1 estimates despite 19% sales decline; ERP transition transient, pricing power validated, insider buying signals conviction.
BSX Q3 margins expanded 60-80 bps driven by FARAPULSE-OPAL integration and WATCHMAN momentum, offsetting tariffs.
Q3 beat and guidance raise validate execution. Direct sales +85%, ACC migrations accelerate, AI monetization framework emerges.
Political attack on $42B mandate converges with credit fraud probe, testing BlackRock's institutional credibility amid portfolio stress.
U.S. equities advance into midday with Energy, Staples, and Materials leading while volatility retreats; Fed uncertainty and mixed data keep tone selective.
Stocks extended gains Tuesday as cyclicals led and volatility eased. Overnight headlines on TPUs, tariffs, and rate-cut odds set up today’s open.
Equities built on midday gains into the close as volatility fell. Cyclicals led while semis split, with NVDA and AMD lower even as ADI and AMAT climbed.
Stocks extend early gains into midday as cyclicals lead, semis lag, and volatility eases. We unpack rotation, Fed cut odds, and key movers with verified data.
Truist raises target to $240, JPMorgan to $230 post-Q3 earnings. Consensus reprices +9.8% to $229.69 as institutional conviction solidifies around bull-case.
FY2025 earnings show 61.5% gross margin and 26.6% operating margin, validating asset-light strategy ahead of Penang divestiture.
Unusual put option surge and analyst downgrades signal institutional doubts about Colgate's valuation and growth trajectory.
Missouri PSC approves large-load rate structure for Powering Missouri Growth Plan, operationalizing earnings accretion pathway.
Paramount Skydance's CNN commitment and Ellison-Trump alignment give white-glove regulatory approval versus Comcast and Netflix's multi-year legal battles.
Weyerhaeuser's 186% earnings beat failed to prevent analyst targets from falling 7.6%, exposing the fragility of the bull thesis when policy remains uncertain.
XOM freezes blue hydrogen capex amid weak demand while acquiring Permian NGL pipeline stake, signaling ruthless capital discipline.
Post-earnings margin validation, analyst consensus upshift to $200, and fresh $1.0B buyback authorization signal management conviction.
Q3 earnings beat and guidance raise validate specialty pharma pivot with Q1 2026 strategic catalyst.
Operating income guidance tightening alongside revenue raise signals management no longer confident in sustained margin expansion amid parked domain pressures.
Settlement removes major overhang as analyst consensus signals modest recovery; margin pressure persists.
Q3 comp sales accelerate to 5%, earnings beat, guidance raised—but market's muted reaction signals valuation premium already priced for perfection.
Management targets 21% operating margins and $17B sales, prompting consensus estimates to jump 31%, reframing insider sales as opportune harvesting.
Segment deceleration and negative result in Engineered Systems suggest Teledyne's diversification thesis is fraying as commercial end-markets soften.
AMD MI355X platform launch signals multi-vendor GPU strategy, de-risking margin recovery thesis and expanding addressable market beyond Blackwell.
Incoming NYC administration's boycott threat forces Niccol to reprice labour settlement costs, even as consumer resilience validates the turnaround.
Revvity's ACD/Labs acquisition and 20% software growth signal management confidence in margin expansion and portfolio shift toward recurring revenue.
Hedge funds accumulate shares as insiders sell, creating bifurcated positioning on the cybersecurity platform provider's margin recovery trajectory.